ZyVersa Therapeutics, Inc. (ZVSA)
OTCMKTS · Delayed Price · Currency is USD
0.1600
-0.0200 (-11.11%)
At close: Feb 6, 2026
ZyVersa Therapeutics Market Cap
ZyVersa Therapeutics has a market cap or net worth of $1.3 million as of February 9, 2026. Its market cap has decreased by -65.80% in one year.
Market Cap
1.30M
Enterprise Value
767.37K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.16
Market Cap Chart
Since February 10, 2022, ZyVersa Therapeutics's market cap has decreased from 95.47M to 1.30M, a decrease of -98.64%. That is a compound annual growth rate of -65.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 1.30M | 19.76% |
| Dec 31, 2025 | 1.08M | -59.32% |
| Dec 31, 2024 | 2.66M | -43.66% |
| Dec 29, 2023 | 4.72M | -66.90% |
| Dec 30, 2022 | 14.26M | -85.07% |
| Feb 10, 2022 | 95.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Agentix | 1.68M |
| Galera Therapeutics | 1.66M |
| inTerra Resources | 1.49M |
| Sorrento Therapeutics | 1.36M |
| International Stem Cell | 1.32M |
| Sigyn Therapeutics | 1.20M |
| CERo Therapeutics Holdings | 1.20M |
| Halberd | 1.20M |